Ublituximab: A Novel Anti-CD20 Therapy for Multiple Sclerosis - touchNEUROLOGY
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Comparison of commercially available anti-CD20 antibodies | Download Table
Antibody drug development: Targeting CD20 and CD3
HEK293 Expressed Full Length CD20 Protein with Nanodisc / DDM - ACROBiosystems
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises | Immunotherapy
CD20 Monoclonal Antibodies Drugs: There is an Explosion of New mAbs Against CD20! - Cusabio
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
The future of anti-CD 20 monoclonal antibodies : are we making progress ? | Semantic Scholar
Noninvasive Evaluation of CD20 Expression Using 64Cu-Labeled F(ab′)2 Fragments of Obinutuzumab in Lymphoma | Journal of Nuclear Medicine
CD20 - Wikipedia
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance | Oncogene
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises | Immunotherapy
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
Treatment of multiple sclerosis with anti-CD20 antibodies. | Semantic Scholar
Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Anti-CD20 monoclonal antibodies: historical and future perspectives | Haematologica
Anti-tumor antibody (anti-CD20)-opsonized tumor cells (A) and... | Download Scientific Diagram
Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
AntiCD20+ Agents - Practical Neurology
anti-CD20 (Rituximab) - ACE Biolabs Antibody │ Chemical │ Enzyme
Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy | PNAS
Anti-CD20 Directed Therapy of B Cell Lymphomas: Are New Agents Really Better? | SpringerLink
Unraveling the T–B tangle in anti-CD20 multiple sclerosis therapy | PNAS
